Advertisement

Topics

Augmenix, Inc. Company Profile

10:53 EDT 22nd March 2019 | BioPortfolio

Augmenix, Inc. is a privately held company based in Waltham, Mass., focused on the development and commercialization of implantable biomaterial based solutions for improved radiotherapy safety and/or efficacy. Augmenix's first product, SpaceOAR system is an injectable tissue spacer that will decrease rectal morbidity or enable improved efficacy in prostate radiotherapy. The company was founded in 2008.


News Articles [9 Associated News Articles listed on BioPortfolio]

Boston Scientific to buy prostate therapy developer Augmenix in $600m deal

Augmenix is a privately-held company which has developed and commercialized the SpaceOAR system, a therapy used to reduce common and debilitating side effects that men may experience after The post B...

Boston Scientific finalizes $600M deal to buy Augmenix

Boston Scientific has announced completion of its acquisition of Augmenix, valued at $500 million in cash upfront plus $100 m -More- 

Boston Scientific acquires Massachusetts─based Augmenix for $600 million

Boston Scientific, a global medical technology leader, has entered into a definitive agreement to acquire Augmenix, Inc., a privately─held company which has developed and commercialized the SpaceOAR...

Boston Scientific shells out $500mm up front for Augmenix

In its seventh acquisition this year, Boston Scientific Corp. is paying $500mm in cash to acquire closely held device maker Augmenix Inc. The transaction also includes up to $100mm in sales-based earn...

Boston Scientific Announces Agreement To Acquire Augmenix, Inc.

Acquisition expands portfolio of men's health in-office procedures with adjunctive therapy for prostate cancer patients MARLBOROUGH, Mass., Sept. 6, 2018 /PRNewswire/ -- Boston Scientific (NYSE: BS...

Boston Scientific to acquire Augmenix for $500M

Boston Scientific To Acquire Augmenix For Prostate Tech

Boston Scientific Closes Acquisition of Augmenix, Inc.

MARLBOROUGH, Mass., Oct. 16, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Augmenix, Inc., a privately-held company that developed an...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Augmenix, Inc.

Augmenix, Inc. is a privately held company based in Waltham, Mass., focused on the development and commercialization of implantable biomaterial based solutions for improved radiotherapy safety and/or ...

Augmenix Inc.

More Information about "Augmenix, Inc." on BioPortfolio

We have published hundreds of Augmenix, Inc. news stories on BioPortfolio along with dozens of Augmenix, Inc. Clinical Trials and PubMed Articles about Augmenix, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Augmenix, Inc. Companies in our database. You can also find out about relevant Augmenix, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biomaterial
A biomaterial is defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic proc...


Corporate Database Quicklinks



Searches Linking to this Company Record